PepGen Inc
Nasdaq PEPG · Boston, MA
Works in Genetic & rare · Musculoskeletal · Neurology
PepGen Inc is a clinical trial sponsor based in Boston, MA, listed as Nasdaq PEPG. It has 2 active clinical trials with 72 planned participants, in Genetic & rare, Musculoskeletal and Neurology. Since 2021 it has completed 1 trial and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq PEPG
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about PepGen Inc
PepGen Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 72 planned participants, in Genetic & rare, Musculoskeletal, Neurology. Since 2021 it has completed 1 trial and stopped 2 early.
PepGen Inc is based in Boston, MA and is listed as Nasdaq PEPG. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with PepGen Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-07-29.
Approve Suite is not affiliated with PepGen Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.